SKIN · SkinHealth Systems Inc. · Share Buybacks
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Concurrent Repurchase Programs
| Authorized | As of | Remaining | Remaining as of | Source |
|---|---|---|---|---|
| $100,000,000 | 2023-09-12 | — | — | 10-K, filed 2026-03-12 |
| $200,000,000 | 2022-11-09 | — | — | 10-K, filed 2026-03-12 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-03-12 |
| 2024-12-31 | $0 | 10-K, filed 2026-03-12 |
| 2023-12-31 | $30,155,000 | 10-K, filed 2026-03-12 |
| 2022-12-31 | $160,000,000 | 10-K, filed 2025-03-12 |
| 2021-12-31 | $0 | 10-K, filed 2024-03-12 |
| 2020-12-31 | $154,000 | 10-K, filed 2023-03-01 |
| 2019-12-31 | $0 | 10-K, filed 2022-03-01 |
Share counts and average prices are restated onto today's share basis across later stock splits; cash spent is as reported. ‡ marks a row kept as filed because a later split could not be attributed to this stock's shares.